Form 10-Q
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2010 or

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission File Number 0-21229

 

 

Stericycle, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   36-3640402

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification Number)

28161 North Keith Drive

Lake Forest, Illinois 60045

(Address of principal executive offices, including zip code)

(847) 367-5910

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file reports), and (2) has been subject to such filing requirements for the past 90 days.    YES  x    NO  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    YES  x    NO  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definition of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   x    Accelerated filer   ¨
Non-accelerated filer   ¨      Smaller reporting company   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    YES  ¨    NO  x

As of July 30, 2010 there were 85,299,835 shares of the registrant’s Common Stock outstanding.

 

 

 


Table of Contents

LOGO

Stericycle, Inc.

Table of Contents

 

          Page No.

PART I. Financial Information

  

Item 1.

  

Financial Statements

  
  

Condensed Consolidated Balance Sheets as of June 30, 2010 (Unaudited) and December 31, 2009 (Audited)

   1
  

Condensed Consolidated Statements of Income for the three and six months ended June 30, 2010 and 2009 (Unaudited)

   2
  

Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2010 and 2009 (Unaudited)

   3
  

Condensed Consolidated Statements of Changes in Equity for the six months ended June 30, 2010 (Unaudited) and December 31, 2009 (Audited)

   4
  

Notes to Condensed Consolidated Financial Statements (Unaudited)

   5

Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

   17

Item 3.

  

Qualitative and Quantitative Disclosures about Market Risk

   24

Item 4.

  

Controls and Procedures

   25

PART II. Other Information

  

Item 1.

  

Legal Proceedings

   27

Item 2.

  

Changes in Securities, Uses of Proceeds and Issuer Purchases of Equity Securities

   27

Item 6.

  

Exhibits

   28

Signatures

   29

Certifications

   30


Table of Contents

PART I. – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

STERICYCLE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

In thousands, except share and per share data

 
     June 30,
2010
    December 31,
2009
 
     (Unaudited)     (Audited)  

ASSETS

    

Current Assets:

    

Cash and cash equivalents

   $ 8,251      $ 15,767  

Short-term investments

     2,234        1,131  

Accounts receivable, less allowance for doubtful accounts of $9,592 in 2010 and $8,709 in 2009

     194,306        179,770  

Deferred income taxes

     16,458        14,087  

Prepaid expenses

     13,836        12,421  

Other current assets

     25,975        23,364  
                

Total Current Assets

     261,060        246,540  

Property, Plant and Equipment, net

     252,391        246,154  

Other Assets:

    

Goodwill

     1,452,051        1,394,091  

Intangible assets, less accumulated amortization of $22,322 in 2010 and $18,546 in 2009

     309,562        269,454  

Other

     25,924        26,564  
                

Total Other Assets

     1,787,537        1,690,109  
                

Total Assets

   $ 2,300,988      $ 2,182,803  
                

LIABILITIES AND SHAREHOLDERS’ EQUITY

    

Current liabilities:

    

Current portion of long-term debt

   $ 92,490      $ 78,026  

Accounts payable

     44,051        47,608  

Accrued liabilities

     99,209        92,226  

Deferred revenues

     16,568        14,954  
                

Total Current Liabilities

     252,318        232,814  

Long-term debt, net of current portion

     859,429        910,825  

Deferred income taxes

     196,061        171,744  

Other liabilities

     13,777        10,247  

Shareholders’ Equity:

    

Common stock (par value $.01 per share, 120,000,000 shares authorized, 85,380,255 issued and outstanding in 2010 and 84,715,005 issued and outstanding in 2009)

     854        847  

Additional paid-in capital

     69,410        47,522  

Accumulated other comprehensive income

     (31,892     (12,292 )

Retained earnings

     910,831        809,618  
                

Total Stericycle, Inc. Shareholders’ Equity

     949,203        845,695   

Noncontrolling interest

     30,200        11,478   
                

Total Shareholders’ Equity

     979,403        857,173   
                

Total Liabilities and Shareholders’ Equity

   $ 2,300,988      $ 2,182,803   
                

The accompanying notes are an integral part of these financial statements.

 

1


Table of Contents

STERICYCLE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(Unaudited)

 

In thousands, except share and per share data

 
     Three Months Ended
June  30,
    Six Months Ended
June  30,
 
     2010     2009     2010     2009  

Revenues

   $ 347,734      $ 289,268      $ 682,911      $ 566,358   

Costs and Expenses:

        

Cost of revenues

     176,540        145,618        347,110        288,212   

Selling, general and administrative expenses

     63,564        53,047        126,034        103,778   

Depreciation and amortization

     12,617        9,660        25,006        18,504   

Acquisition related transaction expenses

     556        1,330        1,356        1,940   

Acquisition integration expenses

     1,314        73        2,463        184   

Restructuring costs and plant closure expense

     1,563        —          2,230        —     

Litigation settlement

     937        —          937        —     

Gain on sale of assets

     (2,955     —          (2,955     —     
                                

Total Costs and Expenses

     254,136        209,728        502,181        412,618   
                                

Income from Operations

     93,598        79,540        180,730        153,740   
                                

Other Income (Expense):

        

Interest income

     32        49        112        223   

Interest expense

     (8,870     (8,200     (17,833     (16,299

Other expense, net

     (892     (828     (1,895     (1,618
                                

Total Other Expense

     (9,730     (8,979     (19,616     (17,694
                                

Income Before Income Taxes

     83,868        70,561        161,114        136,046   

Income Tax Expense

     30,102        26,567        58,714        51,378   
                                

Net Income

   $ 53,766      $ 43,994      $ 102,400      $ 84,668   

Net Income attributable to noncontrolling interests

     672        92        1,187        111   

Net Income attributable to Stericycle, Inc.

   $ 53,094      $ 43,902      $ 101,213      $ 84,557   
                                

Earnings Per Common Share:

        

Basic

   $ 0.63      $ 0.52      $ 1.19      $ 1.00   
                                

Diluted

   $ 0.61      $ 0.51      $ 1.17      $ 0.97   
                                

Weighted Average Number of Common Shares Outstanding:

        

Basic

     84,890,285        84,919,498       84,828,844        84,914,145   

Diluted

     86,694,239        86,843,260       86,646,109        86,843,043   

The accompanying notes are an integral part of these financial statements.

 

2


Table of Contents

STERICYCLE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

In thousands

 
     Six Months Ended June 30,  
     2010     2009  

OPERATING ACTIVITIES:

    

Net income

   $ 102,400     $ 84,668  

Adjustments to reconcile net income to net cash provided by operating activities:

    

Gain on sale of assets

     (2,955 )     —     

Stock compensation expense

     7,741       7,092  

Excess tax benefit of stock options exercised

     (13,430 )     (551 )

Depreciation

     20,872       16,118  

Amortization

     4,134       2,386  

Deferred income taxes

     12,110       11,976  

Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:

    

Accounts receivable

     (11,688     12,302   

Accounts payable

     (5,436     (7,806

Accrued liabilities

     9,042       (1,620 )

Deferred revenues

     1,826       181  

Other assets

     4,689       1,456  
                

Net cash provided by operating activities

     129,305       126,202  
                

INVESTING ACTIVITIES:

    

Payments for acquisitions and international investments, net of cash acquired

     (67,826     (60,519

(Purchase of)/proceeds from short-term investments

     (911 )     513  

Proceeds from sale of assets

     8,000       448  

Capital expenditures

     (25,017     (17,904
                

Net cash used in investing activities

     (85,754     (77,462
                

FINANCING ACTIVITIES:

    

Repayment of long-term debt

     (44,126     (11,383

Net payments on senior credit facility

     (18,249     (71,762

Proceeds from term loan

     —          50,000   

Payments of deferred financing costs

     —          (888

Payments on capital lease obligations

     (1,829     (122

Purchase/ cancellation of treasury stock

     (24,260     (29,975

Proceeds from other issuance of common stock

     25,334       9,163  

Excess tax benefit of stock options exercised

     13,430        551   
                

Net cash used in financing activities

     (49,700     (54,416

Effect of exchange rate changes on cash

     (1,367     (737
                

Net decrease in cash and cash equivalents

     (7,516     (6,413

Cash and cash equivalents at beginning of period

     15,767       9,095  
                

Cash and cash equivalents at end of period

   $ 8,251     $ 2,682  
                

NON-CASH ACTIVITIES:

    

Net issuance of notes payable for certain acquisitions

   $ 31,042     $ 20,756  

The accompanying notes are an integral part of these financial statements.

 

3


Table of Contents

STERICYCLE, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

June 30, 2010 (Unaudited) and

Year Ended December 31, 2009 (Audited)

 

In thousands

                                        
     Stericycle, Inc. Equity             
     Issued
and
Outstanding
Shares
    Common
Stock
    Additional
Paid-In
Capital
    Retained
Earnings
   Accumulated Other
Comprehensive
Income (Loss)
    Noncontrolling
Interest
   Total Equity  

Balance at December 31, 2008

   85,253      $ 852      $ 67,776      $ 633,927    $ (32,075   $ 158    $ 670,638   

Issuance of common stock for exercise of options and employee stock purchases

   1,132        12        15,889        —        —          —        15,901   

Purchase/ Cancellation of treasury stock

   (1,670     (17     (73,164     —        —          —        (73,181

Stock compensation expense

   —          —          14,638        —        —          —        14,638   

Excess tax benefit of disqualifying dispositions of stock options and exercise of non-qualified stock options

   —          —          22,383        —        —          —        22,383   

Change in noncontrolling interest

   —          —          —          —        —          9,787      9,787   

Currency translation adjustment

   —          —          —          —        17,595        835      18,430   

Change in fair value of cash flow hedge, net of tax of $454

   —          —          —          —        2,188        —        2,188   

Net income

   —          —          —          175,691      —          698      176,389   
                      

Comprehensive income

                   197,007   
                                                    

Balance at December 31, 2009

   84,715      $ 847      $ 47,522      $ 809,618    $ (12,292   $ 11,478    $ 857,173   
                                                    

Issuance of common stock for exercise of options and employee stock purchases

   1,108        11        24,973        —        —          —        24,984   

Purchase/ Cancellation of treasury stock

   (443     (4     (24,256     —        —          —        (24,260

Stock compensation expense

   —          —          7,741        —        —          —        7,741   

Excess tax benefit of disqualifying dispositions of stock options and exercise of non-qualified stock options

   —          —          13,430        —        —          —        13,430   

Change in noncontrolling interest

   —          —          —          —        —          17,457      17,457   

Currency translation adjustment

   —          —          —          —        (17,963     78      (17,885

Change in fair value of cash flow hedge, net of tax of $1,047

   —          —          —          —        (1,637     —        (1,637

Net income

   —          —          —          101,213      —          1,187      102,400   
                      

Comprehensive income

                   82,878   
                                                    

Balance at June 30, 2010

   85,380      $ 854      $ 69,410      $ 910,831    $ (31,892   $ 30,200    $ 979,403   
                                                    

The accompanying notes are an integral part of these financial statements.

 

4


Table of Contents

STERICYCLE, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Unless the context requires otherwise, “we”, “us” or “our” refers to Stericycle, Inc. and its subsidiaries on a consolidated basis.

NOTE 1 – BASIS OF PRESENTATION

The accompanying condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations; but the Company believes the disclosures in the accompanying condensed consolidated financial statements are adequate to make the information presented not misleading. In our opinion, all adjustments necessary for a fair presentation for the periods presented have been reflected and are of a normal recurring nature. Current amounts in previously issued financial statements were reclassified to conform to the current period presentation. These condensed consolidated financial statements should be read in conjunction with the Consolidated Financial Statements and notes thereto for the year ended December 31, 2009, as filed with our Annual Report on Form 10-K for the year ended December 31, 2009. The results of operations for the six months ended June 30, 2010 are not necessarily indicative of the results that may be achieved for the entire year ending December 31, 2010.

NOTE 2 – ACQUISITIONS AND DIVESTITURES

During the quarter ended March 31, 2010, we acquired selected assets of two domestic regulated waste businesses, 100% of the stock of two regulated waste businesses in the UK, 70% of the stock of a regulated waste business in Brazil, and 100% of the stock of a regulated waste business in Chile. We also increased our majority share in a previous acquisition in Chile.

During the quarter ended June 30, 2010, we completed four acquisitions. Domestically, we acquired all of the stock of two regulated waste businesses. Internationally, we acquired all of the stock of one regulated waste business located in the United Kingdom and selected assets of a regulated waste business located in Mexico.

The aggregate purchase price of our acquisitions during the six months ended June 30, 2010 was approximately $105.4 million, of which approximately $67.8 million was paid in cash, $31.0 million was paid by the issuance of promissory notes, and $6.6 million was recorded as contingent consideration. For financial reporting purposes, we recognized $76.9 million in goodwill, of which $6.5 million is tax deductible. We recognized $49.8 million in intangible assets of which $32.3 million have amortizable lives of 15-40 years, $0.4 million have amortizable lives of 3-5 years, and $17.1 million are indefinite lived. The allocation of acquisition price is preliminary pending completion of certain intangible asset valuations and completion accounts.

 

5


Table of Contents

In thousands

 
     Preliminary
Allocation of
2010
Acquisitions
    Adjustments
During
Allocation
Period
    Total Allocations  

Fixed assets

   $ 8,325      $ 195      $ 8,520   

Intangibles

     49,807        2,160        51,967   

Goodwill

     76,901        (2,681     74,220   

Net other assets

     4,786        (1,022     3,764   

Debt

     (4,079     900        (3,179

Net deferred tax liabilities

     (12,951     597        (12,354

Noncontrolling interests

     (17,457     —          (17,457
                        
   $ 105,332      $ 149      $ 105,481   

The results of operations of these acquired businesses have been included in the consolidated statements of income from the dates of acquisition. These acquisitions resulted in recognition of goodwill in our financial statements reflecting the complementary strategic fit that the acquired businesses brought to us. During the six month period ended June 30, 2010 and 2009, the Company incurred $1.4 million and $1.9 million, respectively, of third party acquisition related expenses. These expenses are identified on our Condensed Consolidated Statements of Income as Acquisition related transaction expenses.

Our acquisition of MedServe in December of 2009 required us to divest of certain acquired assets. These assets were sold for $8.0 million resulting in a pre-tax gain of $3.0 million. The following table describes the sold assets:

 

In thousands

      
     Asset Group
Sold
 

Fixed assets

   $ (1,565

Intangibles

     (1,127

Goodwill

     (2,345

Net other assets

     (8
        
   $ (5,045 ) 

 

6


Table of Contents

NOTE 3 – NEW ACCOUNTING STANDARDS

Accounting Standards Recently Adopted

Consolidation

On January 1, 2010, Stericycle adopted changes issued by the FASB related to amendments to previous guidance on the consolidation of variable interest entities (“VIE”). This standard clarifies the characteristics that identify a VIE and changes how a reporting entity identifies a primary beneficiary that would consolidate the VIE from a quantitative risk and rewards calculation to a qualitative approach based on which variable interest holder has controlling financial interest and the ability to direct the most significant activities that impact the VIE’s economic performance. This statement requires the primary beneficiary assessment to be performed on a continuous basis. It also requires additional disclosures about an entity’s involvement with a VIE, restrictions on the VIE’s assets and liabilities that are included in the reporting entity’s consolidated balance sheet, significant risk exposures due to the entity’s involvement with the VIE, and how its involvement with a VIE impacts the reporting entity’s consolidated financial statements. Our adoption of the standard did not have an impact to our financial statements.

Accounting Standards not yet adopted

Revenue Recognition

In October 2009, the FASB issued an update to existing guidance on revenue recognition for arrangements with multiple deliverables. This update will allow companies to allocate consideration received for qualified separate deliverables using estimated selling price for both delivered and undelivered items when vendor-specific objective evidence or third-party evidence is unavailable. Additional disclosures discussing the nature of multiple element arrangements, the types of deliverables under the arrangements, the general timing of their delivery, and significant factors and estimates used to determine estimated selling prices are required. We will adopt this update for new revenue arrangements entered into or materially modified beginning January 1, 2011. We do not generally have arrangements with multiple deliverables and therefore do not expect any material impact to our financial statements upon adoption.

NOTE 4 – FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

 

   

Level 1 – Valuations based on quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.

 

   

Level 2 – Valuations based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.

 

   

Level 3 – Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

 

7


Table of Contents

Financial assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement requires judgment, and may affect the valuation of assets and liabilities and their placement within the fair value hierarchy levels. The impact of our creditworthiness has been considered in the fair value measurements noted below. In addition, the fair value measurement of a liability must reflect the nonperformance risk of an entity.

 

In thousands

                   
          Fair Value Measurements Using
     Total as of
June 30,  2010
   Level 1
Inputs
   Level 2
Inputs
   Level 3
Inputs

Assets:

           

Cash and cash equivalents

   $ 8,251    $ 8,251    $ —      $ —  

Short-term investments

     2,234      2,234      —        —  
                           

Total assets

   $ 10,485    $ 10,485    $ —      $ —  

Liabilities:

           

Interest rate hedges (accrued liabilities)

     3,850      —        3,850      —  
                           

Total liabilities

   $ 3,850    $ —      $ 3,850    $ —  

In thousands

                   
          Fair Value Measurements Using
     Total as of
December 31, 2009
   Level 1
Inputs
   Level 2
Inputs
   Level 3
Inputs

Assets:

           

Cash and cash equivalents

   $ 15,767    $ 15,767    $ —      $ —  

Short-term investments

     1,131      1,131      —        —  
                           

Total assets

   $ 16,898    $ 16,898    $ —      $ —  

Liabilities:

           

Interest rate hedges (accrued liabilities)

   $ 1,165    $ —      $ 1,165    $ —  
                           

Total liabilities

   $ 1,165    $ —      $ 1,165    $ —  

Level 1: At June 30, 2010, we have $8.3 million in cash and cash equivalents, and $2.2 million of short-term investments that we carry on our books at fair value using Level 1 inputs. At December 31, 2009, we had $15.8 million in cash and cash equivalents and $1.1 million of short-term investments on our books at fair value using market price inputs.

Level 2: At June 30, 2010, we have an interest rate swap contract covering $25 million of our variable interest debt. The objective of the swaps is to reduce the risk of volatile interest expense by fixing the rate. We also have a Treasury rate lock covering $150 million of our expected private debt placement. The objective of the Treasury rate lock is to reduce the risk of volatile interest expense by fixing a portion of the fixed rate. The interest rate hedges are designated as cash flow hedges; the notional amount and all other significant terms of the hedge agreements are matched to the provisions and terms of the debt hedged. We apply hedge accounting to these instruments with changes in the fair value of the hedge agreements recorded as a component of accumulated other comprehensive income. The fair value was determined using market data inputs to calculate expected future interest rates. The cash streams attributable to the difference between expected future rates and the fixed rate payable is discounted to arrive at the fair value of the two hedges. At June 30, 2010 and December 31, 2009 the fair value of the interest rate hedges was recorded as a current liability of $3.8 million and $1.2 million, respectively.

 

8


Table of Contents

Level 3: We had no assets or liabilities measured at fair value using Level 3 inputs at June 30, 2010 or December 31, 2009.

Fair Value of Debt: At June 30, 2010, the fair value of the Company’s debt obligations was estimated at $949.4 million, compared to a carrying amount of $951.9 million. At December 31, 2009, the fair value of the Company’s debt obligations was estimated at $985.0 million, compared to a carrying amount of $988.9 million. This fair value was estimated using market interest rates for comparable instruments.

There were no movements of items between fair value hierarchies.

NOTE 5 – DERIVATIVE INSTRUMENTS

As of June 30, 2010, we have one interest rate swap contract covering $25 million of our borrowings outstanding under our senior credit facility, and two Treasury rate locks covering $150 million of our expected private debt placement. The objective of the hedges is to reduce the risk of volatile interest expense by fixing the rate. The details of the contracts are as follows:

 

In thousands

    

Notional

Amount

   Fixed
Interest Rate
   

Variable

Interest Rate

  

Expiration

Date

$25,000    2.94  

1 Month Libor

  

October 2010

$75,000    2.799  

7-Year Treasury

  

July 2010

$75,000    3.29  

10-Year Treasury

  

July 2010

We entered into the interest rate hedges in order to manage the risk of interest rate changes to our interest expense. The interest rate hedges are designated as cash flow hedges; the notional amounts and all other significant terms of the hedge agreement are matched to the provisions and terms of the variable rate debt hedged. The fair market of the three hedges is recorded as a current liability of $3.8 million at June 30, 2010. At June 30, 2010, the hedges were determined to be 100% effective. Gains or losses on hedges are reclassified into interest expense when the effect of the hedged item is recognized in earnings. The fair market value was determined using market data inputs to calculate expected future interest rates. The cash streams attributable to the difference between expected future rates and the fixed rate payable is discounted to arrive at the fair value of the hedges.

 

9


Table of Contents

NOTE 6 – INCOME TAXES

We and our subsidiaries file U.S. federal income tax returns and income tax returns in various states and foreign jurisdictions. With a few exceptions, we are no longer subject to U.S. federal, state, local, or non-U.S. income tax examinations by tax authorities for years before 2003. The Internal Revenue Service (“IRS”) concluded an examination of the Company’s U.S. income tax return for 2004. Tax years after 2005 remain open and subject to examination by the IRS. In addition, our subsidiaries in foreign countries have tax years open ranging from 2003 through 2009.

The Company has recorded accruals to cover certain unresolved tax issues. Such contingent liabilities relate to additional taxes and interest the Company may be required to pay in various tax jurisdictions. During the course of examinations by various taxing authorities, proposed adjustments may be asserted. The Company evaluates such items on a case-by-case basis and adjusts the accrual for contingent liabilities as deemed necessary.

The total amount of unrecognized tax benefits as of June 30, 2010 and December 31, 2009 was $9.0 million and $7.6 million, respectively, which included immaterial amounts of interest and penalties reflected as a liability on the balance sheet. The amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate is approximately $9.0 million. We recognize interest and penalties accrued related to income tax reserves in income tax expense. This method of accounting is consistent with prior years.

The following table summarizes the changes in unrecognized tax positions during the six months ended June 30, 2010:

 

In thousands

    

Unrecognized tax positions, January 1, 2010

   $ 7,622

Gross increases- tax positions in current period

     1,400
      

Unrecognized tax positions, June 30, 2010

   $ 9,022
      

NOTE 7 – STOCK BASED COMPENSATION

At June 30, 2010 we had stock options outstanding under the following plans:

 

  (i) The 2008 Incentive Stock Plan, which our stockholders approved in May 2008;

 

  (ii) the 2005 Incentive Stock Plan, which our stockholders approved in April 2005;

 

  (iii) the 2000 Nonstatutory Stock Option Plan, which our Board of Directors adopted in February 2000;

 

  (iv) the 1997 Stock Option Plan, which expired in January 2007;

 

  (v) the Directors Stock Option Plan, which expired in May 2006;

 

  (vi) the 1995 Incentive Compensation Plan, which expired in July 2005;

 

  (vii) our Employee Stock Purchase Plan, which our stockholders approved in May 2001.

 

10


Table of Contents

The following table sets forth the expense related to stock compensation:

 

In thousands

     Three Months Ended
June  30,
   Six Months Ended
June  30,
     2010    2009    2010    2009

Stock options / restricted stock units

   $ 3,674    $ 3,465    $ 7,324    $ 6,759

Employee Stock Purchase Program

     193      166      417      333
                           

Total pre-tax expense

   $ 3,867    $ 3,631    $ 7,741    $ 7,092
                           

The following table sets forth the tax benefits related to stock compensation:

 

In thousands

     Three Months Ended
June  30,
   Six Months Ended
June  30,
     2010    2009    2010    2009

Tax benefit recognized in income statement

   $ 1,533    $ 1,452    $ 3,061    $ 2,754

Excess tax benefit realized

     12,267      287      13,430      551

The Black-Scholes option-pricing model is used in determining the fair value of each option grant using the assumptions noted in the table below. The expected term of options granted is based on historical experience and represents the period of time that awards granted are expected to be outstanding. Expected volatility is based upon historical volatility of the company’s stock. The expected dividend yield is zero. The risk-free interest rate is based upon the U.S. Treasury yield rates of a comparable period.

The assumptions that we used in the Black-Scholes model are as follows:

 

     Three Months Ended
June  30,
    Six Months Ended
June  30,
 
     2010     2009     2010     2009  

Expected term (in years)

     5.75        5.5        5.75        5.5   

Expected volatility

     29.69     28.90     28.42     28.28

Expected dividend yield

     0.00     0.00     0.00     0.00

Risk free interest rate

     1.75     2.34     2.41     2.12

Weighted average fair value at grant date

   $ 16.29      $ 13.87      $ 13.36      $ 11.89   

Stock option activity for the six months ended June 30, 2010, was as follows:

 

     Number of
Options
    Weighted
Average
Exercise
Price per
Share
   Weighted
Average
Remaining
Contractual
Life
   Aggregate
Intrinsic
Value
                (in years)     

Outstanding at December 31, 2009

   7,387,753      $ 35.43      

Granted

   1,262,823        52.17      

Exercised

   (1,231,078     25.24      

Cancelled or expired

   (104,678     47.78      
                  

Outstanding at June 30, 2010

   7,314,820      $ 39.82    6.86    $ 189,244,650
                  

Exercisable at June 30, 2010

   3,868,401      $ 33.17    5.61    $ 125,385,543

Vested and expected to vest in the future at June 30, 2010

   6,685,358      $ 38.97    6.69    $ 178,460,762

 

11


Table of Contents

The total intrinsic value of options exercised for the three and six months ended June 30, 2010 and 2009 was $37.5 million and $4.7 million, and $41.8 million and $8.9 million, respectively. Intrinsic value is measured using the fair market value at the date of the exercise (for options exercised) or at June 30, 2010 (for outstanding options), less the applicable exercise price. The restricted stock units (RSUs), included above, account for 20,000 shares granted and $1.3 million of intrinsic value which have a weighted average contractual life of 2.6 years.

As of June 30, 2010, there was $28.0 million of total unrecognized compensation expense, related to non-vested stock options, which is expected to be recognized over a weighted average period of 1.91 years.

NOTE 8 – COMMON STOCK

During the quarters ended March 31, 2010 and 2009, we repurchased on the open market, and subsequently cancelled, 207,114 and 536,346 shares of common stock, respectively. The weighted average repurchase price was $54.36 and $47.59 per share, respectively. There was $0.6 million of share repurchases that were not settled as of March 31, 2010.

During the quarters ended June 30, 2010 and 2009, we repurchased on the open market, and subsequently cancelled, 235,436 and 40,162 shares of common stock, respectively. The weighted average repurchase price was $55.22 and $48.51 per share, respectively. We also settled $0.6 million of share repurchases that occurred during the quarter ended March 31, 2010.

NOTE 9 – NET INCOME PER COMMON SHARE

The following table sets forth the computation of basic and diluted net income per share:

 

In thousands, except share and per share data

     Three Months Ended
June 30,
   Six Months Ended
June 30,
     2010    2009    2010    2009

Numerator:

           

Numerator for basic earnings per share

           

Net income attributable to Stericycle, Inc.

   $ 53,094    $ 43,902    $ 101,213    $ 84,557
                           

Denominator:

           

Denominator for basic earnings per share weighted average shares

     84,890,285      84,919,498      84,828,844      84,914,145

Effect of diluted securities:

           

Employee stock options

     1,803,954      1,923,762      1,817,265      1,928,898
                           

Dilutive potential shares

     1,803,954      1,923,762      1,817,265      1,928,898
                           

Denominator for diluted earnings per share-adjusted weighted average shares and after assumed conversions

     86,694,239      86,843,260      86,646,109      86,843,043
                           

Earnings per share – Basic

   $ 0.63    $ 0.52    $ 1.19    $ 1.00
                           

Earnings per share – Diluted

   $ 0.61    $ 0.51    $ 1.17    $ 0.97
                           

 

12


Table of Contents

NOTE 10 – COMPREHENSIVE INCOME

The components of total comprehensive income are net income, the change in cumulative currency translation adjustments and gains and losses on derivative instruments qualifying as cash flow hedges. The following table sets forth the components of total comprehensive income for the three and six months ended June 30, 2010 and 2009:

 

In thousands

     Three Months Ended
June 30,
   Six Months Ended
June 30,
     2010     2009    2010     2009

Net income

   $ 53,766      $ 43,994    $ 102,400      $ 84,668

Other comprehensive income/ (loss):

         

Currency translation adjustments

     (7,480     25,604      (17,885     20,261

Change in fair value of cash flow hedge, net of tax

     (2,008     634      (1,637     1,007
                             

Other comprehensive income/ (loss)

     (9,488     26,238      (19,522     21,268

Comprehensive income

   $ 44,278      $ 70,232    $ 82,878      $ 105,936

Less: net income attributable to noncontrolling interests

     672        92      1,187        111
                             

Comprehensive income attributable to Stericycle, Inc.

   $ 43,606      $ 70,140    $ 81,691      $ 105,825
                             

NOTE 11 – GOODWILL

We have two geographical reporting segments, United States and Foreign Countries, both of which have goodwill. The changes in the carrying amount of goodwill, for the six months ended June 30, 2010 were as follows:

 

In thousands

 
     United States     Foreign
Countries
    Total  

Balance as of January 1, 2010

   $ 1,153,149      $ 240,942      $ 1,394,091   

Changes due to currency fluctuation

     —          (13,915     (13,915

Sale of assets

     (2,345     —          (2,345

Changes in goodwill on 2009 acquisitions

     (2,469     (212     (2,681

Goodwill on 2010 acquisitions

     35,708        41,193        76,901   
                        

Balance as of June 30, 2010

   $ 1,184,043      $ 268,008      $ 1,452,051   
                        

 

13


Table of Contents

During the quarter ended June 30, 2010 we performed our annual goodwill impairment evaluation for our three reporting units, Domestic Regulated Waste, Domestic Regulated Returns Management, and Foreign Countries. We performed two impairment tests, one using a market approach and the other using an income approach. Both the market and income approaches indicated no impairment to goodwill to any of our three reporting units.

Market Approach: Our market approach begins by calculating the market capitalization of the Company using the average stock price for the prior 30 days and the outstanding share count at June 30, 2010. We then look at the Company’s Earnings Before Interest, Tax, Depreciation, and Amortization (“EBITDA”), adjusted for stock compensation expense and non-core operational expenses, such as a gain on sale of divested assets, for the prior twelve months. The calculated market capitalization is divided by the modified EBITDA to arrive at a valuation multiple. The fair value of each reporting unit is then calculated by taking the product of the valuation multiple and the trailing twelve month modified EBITDA of that reporting unit. The fair value was then compared to the reporting units’ book value and determined to be in excess of the book value. We believe that starting with the fair value of the company as a whole is a reasonable measure as that fair value is then allocated to each reporting unit based on that reporting unit’s individual earnings. A sustained drop in our stock price would have a negative impact to our fair value calculations. A temporary drop in earnings of a reporting unit would have a negative impact to our fair value calculations.

The results of our goodwill impairment test using the market approach indicated the fair value of our Domestic Regulated Waste and Foreign Countries reporting units exceeded book value by a substantial amount, in excess of 100% of book value. Our Regulated Returns Management reporting unit fair value exceeded book value in excess of 30%. We currently have $119.9 million of goodwill assigned to our Regulated Returns Management reporting unit.

Income Approach: The income approach uses expected future cash flows of each reporting unit and discounts those cash flows to a present value. Expected future cash flows are calculated using management assumptions of internal growth, capital expenditures, and cost efficiencies. Future acquisitions are not included in the expected future cash flows. We use a discount rate based on our Company calculated Weighted Average Cost of Capital which is adjusted for each of our reporting units based on risk size premium and foreign country premium. Significant assumptions used in the income approach include realization of future cash flows and the discount rate used to present value those cash flows.

The results of our goodwill impairment test using the income approach indicated the fair value all of our reporting units exceeded book value by a substantial amount; in excess of 100%.

We complete our annual impairment analysis of our indefinite lived intangibles (facility permits) during the quarter ended December 31 of each year.

 

14


Table of Contents

NOTE 12 – GEOGRAPHIC INFORMATION

Management has determined that we have two reportable segments, United States (includes Puerto Rico) and Foreign. Revenues are attributed to countries based on the location of customers. Inter-company revenues, which are immaterial, are eliminated prior to reporting United States revenues. The same accounting principles and critical accounting policies are used in the preparation of the financial statements for both reporting segments.

Detailed information for our United States reporting segment is as follows:

 

In thousands

     Three Months Ended
June 30,
   Six Months Ended
June 30,
     2010    2009    2010    2009

Regulated waste management services

   $ 236,575    $ 207,276    $ 465,665    $ 409,627

Regulated returns management services

     25,415      18,309      51,703      37,998
                           

Total revenue

     261,990      225,585      517,368      447,625
                           

Net interest expense

     7,407      6,744      15,020      13,304

Income before income taxes

     69,601      61,086      134,361      118,081

Income taxes

     25,806      23,647      49,749      45,849
                           

Net income attributable to Stericycle, Inc.

   $ 43,795    $ 37,439    $ 84,612    $ 72,232
                           

Depreciation and amortization

   $ 8,690    $ 7,205    $ 17,386    $ 13,901

Detailed information for our Foreign Countries reporting segment is as follows:

 

In thousands

     Three Months Ended
June 30,
   Six Months Ended
June 30,
     2010    2009    2010    2009

Regulated waste management services

   $ 85,744    $ 63,683    $ 165,543    $ 118,733

Net interest expense

     1,431      1,407      2,701      2,772

Income before income taxes

     14,267      9,475      26,753      17,965

Income taxes

     4,296      2,920      8,965      5,529

Net income

     9,971      6,555      17,788      12,436

Net income attributable to noncontrolling interests

     672      92      1,187      111
                           

Net income attributable to Stericycle, Inc.

   $ 9,299    $ 6,463    $ 16,601    $ 12,325
                           

Depreciation and amortization

   $ 3,927    $ 2,455    $ 7,620    $ 4,603

NOTE 13 – LEGAL PROCEEDINGS

We operate in a highly regulated industry and must deal with regulatory inquiries or investigations from time to time that may be instituted for a variety of reasons. We are also involved in a variety of civil litigation from time to time.

 

15


Table of Contents

On November 30, 2009, we entered into an agreement with the United States Department of Justice (“DOJ”) and the States of Missouri and Nebraska providing clearance under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 that allowed us to complete the acquisition of MedServe, Inc., which we closed on December 4, 2009. Our agreement with the DOJ and the States of Missouri and Nebraska agreement required us to divest certain assets that we acquired from MedServe consisting of an autoclave treatment facility in Newton, Kansas, four transfer stations in Kansas, Oklahoma, Nebraska and Missouri and certain large customer accounts and associated assets related to these facilities. We completed this required divestiture in May 2010 (see Note 2 – Acquisitions and Divestitures). In addition, our agreement requires us for a period of ten years to notify the DOJ and the States of Missouri and Nebraska before acquiring any business that is engaged in both the collection and treatment of infectious waste in Kansas, Missouri, Nebraska or Oklahoma.

During the quarter ended June 30, 2010, we entered into a settlement of litigation related to an acquisition agreement for $0.9 million.

NOTE 14 – GUARANTEE

We have guaranteed a loan to JPMorganChase Bank N.A. on behalf of Shiraishi-Sogyo Co. Ltd (“Shiraishi”). Shiraishi is a customer in Japan that is expanding their medical waste management business and has a one year loan with a current balance of $5.6 million with JPMorganChase Bank N.A. that expires in May 2011. We also have extended notes receivable to Shiraishi for approximately $14.9 million in support of their medical waste business. These amounts are collateralized with the assets of Shiraishi and related companies.

NOTE 15 – RESTRUCTURING CHARGES

In December of 2009, we announced the consolidation of operations within our Returns Management Services business. This consolidation will result in the closure of our facilities in Boynton Beach, Florida and Conyers, Georgia. The operations of those facilities will be moved to our Indianapolis, Indiana location. We have recognized expense of $1.6 million during the fourth quarter of 2009, $0.7 million during the first quarter of 2010, and $1.1 million during the second quarter of 2010 related to this restructuring. We have an accrual balance of $1.0 million related to the restructuring at June 30, 2010. We estimate additional expense of $0.2 million during the remainder of 2010. We believe this restructuring will allow us to maximize the efficiency of our Returns Management Services business at a single location and management infrastructure. In addition to the Returns Management Services restructuring charges, we recognized $0.5 million in expenses related to the consolidation of some redundant plant operations.

 

16


Table of Contents

NOTE 16 – SUBSEQUENT EVENT

The Company evaluated subsequent events through the date of filing this Quarterly Report on Form 10-Q.

On July 19, 2010 we settled the two Treasury lock interest rate hedges for $4.6 million. These hedges are discussed in Note 5 – Derivative Instruments.

On July 22, 2010, Stericycle, Inc. announced that it had received informal commitments from 22 institutional investors to purchase $175 million of new 3.89% seven-year unsecured senior notes and $225 million of new 4.47% ten-year unsecured senior notes. The issuance and sale of these notes to the purchasers is subject to the purchasers’ due diligence and other conditions, including our agreement with the purchasers on the form of a note purchase agreement and other documentation. We expect that the note purchase agreement will be signed in August 2010 and that the new senior notes will be issued in October 2010. We plan to use the proceeds to pay down outstanding bank debt.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

We were incorporated in 1989 and presently serve a very diverse customer base of approximately 471,000 customers throughout the United States, Argentina, Brazil, Canada, Chile, Ireland, Mexico, Portugal, Puerto Rico, Romania, and the United Kingdom. We have fully integrated networks including processing centers, and transfer and collection sites. We use these networks to provide a broad range of services to our customers including regulated waste management services, and regulated return management services. Regulated waste management services include regulated waste removal services, sharps management services, products and services for infection control, and safety and compliance programs. Regulated return management services are physical services provided to companies and individual businesses that assist with the handling of products that are being removed from the supply chain due to recalls and expiration. These services also include advanced notification technology that is used to communicate specific instructions to the users of the product. Our waste treatment technologies include autoclaving, incineration, chemical treatment, and our proprietary electro-thermal-deactivation system. In addition, we have technology licensing agreements with companies located in Japan, Brazil, and South Africa.

There were no material changes in the Company’s critical accounting policies since the filing of its 2009 Form 10-K. As discussed in the 2009 Form 10-K, the preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions that affect the amount of reported assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and revenues and expenses during the periods reported. Actual results may differ from those estimates.

 

17


Table of Contents

Highlights of the three months ended June 30, 2010:

 

   

revenues grew to $347.7 million, a 20.2% increase over $289.3 million for the second quarter 2009;

 

   

second quarter gross margins decreased to 46.5% in 2010 from 47.2% in 2009;

 

   

operating income was $93.6 million, a 17.7% increase from $79.5 million for 2009;

 

   

we incurred a net $0.1 million in non-core operational pre-tax expenses, and;

 

   

cash flow from operations was $48.2 million.

Highlights of the six months ended June 30, 2010:

 

   

revenues grew to $682.9 million, a 20.6% increase over $566.4 million for 2009;

 

   

gross margins decreased to 46.4% from 46.7% in 2009;

 

   

operating income was $180.7 million, a 17.6% increase from $153.7 million for 2009;

 

   

we incurred a net $1.6 million in non-core operational pre-tax expenses, and;

 

   

cash flow from operations was $129.3 million.

During the quarter ending June 30, 2010, we completed our annual goodwill impairment test. The results of that test did not indicate any impairment to our goodwill (see Note 11 - Goodwill, in the Notes to the Condensed Consolidated Financial Statements (Item 1 of Part I)).

THREE MONTHS ENDED JUNE 30, 2010 COMPARED TO THREE MONTHS ENDED JUNE 30, 2009

The following summarizes the Company’s operations:

 

In thousands, except per share data

     Three Months Ended June 30,
     2010    2009
     $     %    $    %

Revenues

   $ 347,734      100.0    $ 289,268    100.0

Cost of revenues

     176,540      50.8      145,618    50.3

Restructuring costs

     726      0.2      —      —  

Depreciation

     8,931      2.5      7,116    2.5
                        

Total cost of revenues

     186,197      53.5      152,734    52.8

Gross profit

     161,537      46.5      136,534    47.2

Selling, general and administrative expenses

     63,564      18.3      53,047    18.3

Depreciation

     1,527      0.4      1,168    0.4

Amortization

     2,159      0.6      1,376    0.5
                        

Total selling, general and administrative expenses

     67,250      19.3      55,591    19.2

Acquisition related transaction expenses

     556      0.2      1,330    0.5

Acquisition integration expenses

     1,314      0.4      73    0.0

Restructuring costs and plant closure expense

     837      0.2      —      —  

Litigation settlement

     937      0.3      —      —  

Gain on sale of assets

     (2,955   -0.8      —      —  
                        

Income from operations

     93,598      26.9      79,540    27.5

Net interest expense

     8,838      2.5      8,151    2.8

Income tax expense

     30,102      8.7      26,567    9.2

Net income

     53,766      15.5      43,994    15.2

Net income attributable to noncontrolling interests

     672      0.2      92    0.0
                        

Net income attributable to Stericycle, Inc.

   $ 53,094      15.3    $ 43,902    15.2

Earnings per share- diluted

   $ 0.61         $ 0.51   

 

18


Table of Contents

Revenues: Our revenues increased $58.5 million, or 20.2%, to $347.7 million in 2010 from $289.3 million in 2009. Domestic revenues increased $36.4 million, or 16.1%, to $262.0 million from $225.6 million in 2010 as internal revenue growth for domestic small account customers increased by approximately $11.8 million, or approximately 9%, and internal revenue growth for large quantity customers increased by approximately $4.8 million, or approximately 6%. Internal revenue for returns management increased by $7.1 million, and domestic acquisitions less than one year old contributed approximately $12.7 million to the increase in domestic revenues.

International revenues increased $22.1 million to $85.7 million, or 34.6%, from $63.7 million in 2009. Internal growth in the international segment contributed $5.6 million, or over 9% in increased revenues, excluding the effect of exchange rates and acquisitions. The effect of exchange rate fluctuations had no impact on international revenues in the second quarter of 2010, and acquisitions less than one year old contributed an additional $16.5 million in international revenues.

Cost of Revenues: Our cost of revenues increased $33.5 million, or 21.9%, to $186.2 million during 2010 from $152.7 million during 2009. Our domestic cost of revenues increased $20.7 million, or 18.5%, to $132.3 million from $111.6 million in 2009 as a result of costs related to a proportional increase in revenues from acquisitions and internal growth. Our international cost of revenues increased $12.8 million, or 31.1% to $53.9 million from $41.1 million in 2009 as a result of costs related to proportional increase in revenues from acquisitions and internal growth. Our company wide gross margin percentage decreased to 46.5% during 2010 from 47.2% during 2009 due to slightly higher fuel and energy costs as well as integration of newly acquired revenues, such as the Medserve acquisition, which have lower margins, offset by improvements in the base business margins.

Selling, General and Administrative Expenses: Selling, general and administrative expenses (“SG&A”) increased $11.7 million, or 21.0%, to $67.3 million, for the quarter ended June 30, 2010 from $55.6 million for the comparable quarter in 2009 primarily as investment spending supported the increase in revenues and acquisition related SG&A spending. As a percentage of revenue, these costs slightly increased by 0.1% for the quarter ended June 30, 2010 compared to the same period in 2009.

 

19


Table of Contents

Domestically, second quarter 2010 SG&A increased $7.7 million to $51.8 million from $44.1 million in the same period last year. As a percentage of revenues, SG&A was relatively the same at 19.7% in 2010 compared to 19.6% in 2009.

Internationally, our SG&A increased $4.0 million during the quarter ended June 30, 2010 to $15.5 million from $11.5 million during the same period in 2010. As a percentage of revenues, SG&A was 18.1% in 2010 compared to 17.9% in 2009. The slight increase in SG&A was due to our acquisitions in the UK and Brazil, which have slightly higher relative SG&A expenses.

Income from Operations: Income from operations increased to $93.6 million for the three months ended June 30, 2010 from $79.5 million for the comparable quarter in 2009, an increase of 17.7%. During the quarter ended June 30, 2010, we recognized $0.6 million in transactional expenses related to acquisitions as a result of adopting changes issued by the FASB to accounting rules related to business combinations, $1.1 million of restructuring costs of our regulated returns management service business, $0.5 million plant closure expense, and litigation settlement of $0.9 million, offset by a $3.0 million gain on sale of assets related to the MedServe divestiture. These non-core operational expenses totaled $0.1 million on a pre-tax basis. During the quarter ended June 30, 2009, we recognized $1.3 million in transactional expenses related to acquisitions.

Net Interest Expense: Net interest expense increased to $8.8 million during the quarter ended June 30, 2010 from $8.2 million during the comparable quarter in 2009 due to increased borrowings.

Income Tax Expense: Income tax expense increased to $30.1 million for the quarter ended June 30, 2010 from $26.6 million for the comparable quarter in 2009. The increase was due to higher taxable income. The effective tax rates for the quarters ended June 30, 2010 and 2009 were 35.9% and 37.7%, respectively.

SIX MONTHS ENDED JUNE 30, 2010 COMPARED TO SIX MONTHS ENDED JUNE 30, 2009

The following summarizes the Company’s operations:

 

In thousands, except per share data

     Six Months Ended June 30,
     2010    2009
     $     %    $    %

Revenues

   $ 682,911      100.0    $ 566,358    100.0

Cost of revenues

     347,110      50.8      288,212    50.9

Restructuring costs

     1,154      0.2      —      —  

Depreciation

     17,793      2.6      13,809    2.4
                        

Total cost of revenues

     366,057      53.6      302,021    53.3

Gross profit

     316,854      46.4      264,337    46.7

Selling, general and administrative expenses

     126,034      18.5      103,778    18.3

Depreciation

     3,079      0.4      2,309    0.4

Amortization

     4,134      0.6      2,386    0.4
                        

Total selling, general and administrative expenses

     133,247      19.5      108,473    19.2

Acquisition related transaction expenses

     1,356      0.2      1,940    0.3

Acquisition integration expenses

     2,463      0.4      184    0.0

Restructuring costs and plant closure expense

     1,076      0.2      —      —  

Litigation settlement

     937      0.1      —      —  

Gain on sale of assets

     (2,955   -0.4      —      —  
                        

Income from operations

     180,730      26.5      153,740    27.1

Net interest expense

     17,721      2.6      16,076    2.8

Income tax expense

     58,714      8.6      51,378    9.1

Net income

     102,400      15.0      84,668    14.9

Net income attributable to noncontrolling interests

     1,187      0.2      111    0.0
                        

Net income attributable to Stericycle, Inc.

   $ 101,213      14.8    $ 84,557    14.9

Earnings per share- diluted

   $ 1.17         $ 0.97   

 

20


Table of Contents

Revenues: Our revenues increased $116.6 million, or 20.6%, to $682.9 million in 2010 from $566.4 million in 2009. Domestic revenues increased $69.7 million, or 15.6%, to $517.4 million from $447.6 million in 2009 as internal revenue growth for domestic small account customers increased by approximately $21.7 million, or over 8%, and internal revenue growth for large quantity customers increased by approximately $8.5 million, or approximately 6%. Internal revenue for returns management increased by $13.7 million, and domestic acquisitions less than one year old contributed approximately $25.8 million to the increase in domestic revenues.

International revenues increased $46.8 million to $165.5 million, or 39.4%, from $118.7 million in 2009. Internal growth in the international segment contributed $9.5 million, or approximately 8% in increased revenues, excluding the effect of exchange rates and acquisitions. The effect of exchange rate fluctuations favorably impacted international revenues approximately $5.1 million, and acquisitions less than one year old contributed an additional $32.2 million in international revenues.

Cost of Revenues: Our cost of revenues increased $64.0 million, or 21.2%, to $366.0 million during 2010 from $302.0 million during 2009. Our domestic cost of revenues increased $35.9 million, or 15.9%, to $261.2 million from $225.3 million in 2009 as a result of costs related to a proportional increase in revenues from acquisitions and internal growth. Our international cost of revenues increased $28.1 million, or 36.6% to $104.8 million from $76.7 million in 2009 as a result of costs related to proportional increase in revenues, partially driven by the impact of exchange rates. Our gross margin percentage decreased to 46.4% during 2010 from 46.7% during 2009 due to slightly higher energy expenses and the inclusion of lower margin acquired revenues.

Selling, General and Administrative Expenses: SG&A increased $24.8 million, or 22.8%, to $133.2 million, for the six months ended June 30, 2010 from $108.5 million for the comparable period in 2009. As a percentage of revenue, these costs increased by 0.3% for the six months ended June 30, 2010 compared to the same period in 2009.

Domestically, 2010 SG&A increased $15.4 million, or 17.6%, to $103.1 million from $87.7 million in 2009. The increase was primarily due to SG&A expenses related to the acquired revenues, higher amortization and stock option expenses, market penetration for our Sharps Management and Pharmaceutical Waste programs, and investment in the Steri-Safe services.

 

21


Table of Contents

Internationally, our SG&A increased $9.4 million, or 44.7%, to $30.1 million in 2010 from $20.8 million in 2009. As a percentage of revenues, SG&A was 18.2% in 2010 and 17.5% in 2009. The increase in SG&A was partially due to our acquisitions in the UK and Brazil, which have slightly higher relative SG&A expenses. Higher amortization expense related to recognized intangible assets from acquisitions and investments for our Clinical Services program also contributed to the increase in SG&A.

Income from Operations: Income from operations increased $27.0 million, or 17.6%, to $180.7 million for the six months ended June 30, 2010 from $153.7 million for the comparable period in 2009. During the six months ended June 30, 2010, we recognized $1.4 million in transactional expenses related to acquisitions as result of adopting changes issued by FASB to accounting rules related to business combinations, $1.8 million of restructuring costs of our regulated returns management service business, $0.5 million plant closure expense, and litigation settlement of $0.9 million, partially offset by a $3.0 million gain on sale of assets related to the MedServe divestiture. These non-core operational expenses totaled $1.6 million on a pre-tax basis. During the six months ended June 30, 2009, we recognized $1.9 million in transactional expenses related to acquisitions.

Net Interest Expense: Net interest expense increased to $17.7 million during the six months ended June 30, 2010 from $16.1 million during the comparable period in 2009 due to increased borrowings.

Income Tax Expense: Income tax expense increased to $58.7 million for the six months ended June 30, 2010 from $51.4 million for the comparable period in 2009. The increase was due to higher taxable income. The effective tax rates for the six months ended June 30, 2010 and 2009 were 36.4% and 37.8%, respectively.

LIQUIDITY AND CAPITAL RESOURCES

Our $850 million senior credit facility maturing in August 2012, our $211 million term loan maturing in June 2012, and our $100 million private placement notes maturing April 2015, all require us to comply with various financial, reporting and other covenants and restrictions, including a restriction on dividend payments. The financial debt covenants are the same for the senior credit facility, the term loan credit agreement and the private placement notes. At June 30, 2010, we were in compliance with all of our financial debt covenants.

As of June 30, 2010, we had $359.2 million of borrowings outstanding under our $850 million senior unsecured credit facility, which includes foreign currency borrowings of $24.7 million. We also had $193.7 million committed to outstanding letters of credit under this facility. The unused portion of the revolving credit facility as of June 30, 2010 was $297.1 million. At June 30, 2010, our interest rates on borrowings under our revolving credit facility were

 

   

For short-term borrowing (less than one month): Federal funds rate plus 0.5% or prime rate, whichever is higher; and

 

22


Table of Contents
   

For borrowing greater than one month: LIBOR plus 0.75%.

The weighted average rate of interest on the unsecured revolving credit facility was 1.17% per annum.

As of June 30, 2010, we had $211.0 million term loan debt outstanding which was entered into during 2009 with several lenders maturing in June 2012. Term loans under the term loan credit agreement bear interest at fluctuating interest rates determined, for any one-month or other applicable interest period, by reference to the LIBOR plus the applicable margin provided in the term loan agreement. The applicable margin is based on our consolidated leverage ratio and ranges from 2.75% to 3.50%. As of June 30, 2010, the applicable margin was 3.00%. The weighted average rate of interest on the term loan was 3.65% per annum which includes the amounts under our interest rate hedge. We are required to make quarterly principal payments ranging between 2% to 3% of the principal amount of the outstanding term loans, and the remainder at maturity.

As of June 30, 2010, we had $100.0 million outstanding 5.64% private placement notes which we entered into on April 15, 2008 with nine institutional purchasers. The notes bear interest at the fixed rate of 5.64% per annum. Interest is payable in arrears semi-annually on April 15 and October 15 beginning on October 15, 2009, and principal is payable at the maturity of the notes on April 15, 2015.

At June 30, 2010, we had $281.7 million in other debt outstanding, which includes promissory notes issued in connection with acquisitions during 2004 through 2010, other foreign subsidiary bank debt, and capital leases.

Working Capital: At June 30, 2010, our working capital decreased by $5.0 million to $8.7 million compared to $13.7 million at December 31, 2009. Working capital increased by $14.5 million for net accounts receivables related to higher sales. Working capital decreased by $14.5 million for increases in current debt, which was used to fund acquisitions and stock repurchases. Working capital also decreased due to an increase in the fair value liability of $2.7 million related to our interest rate hedges. Increases in other accrued liabilities were mostly offset by decreases in accounts payable.

Net Cash Provided or Used: Net cash provided by operating activities increased $3.1 million, or 2.5%, to $129.3 million during the six months ended June 30, 2010 compared to $126.2 million for the comparable period in 2009. The increase in operating cash was primarily due to higher earnings.

Net cash used in investing activities for the six months ended June 30, 2010 was $85.8 million compared to $77.5 million in the comparable period in 2009. The difference is due to an increase of $7.3 million on acquisitions and international investments in the first six months of 2010 than for the same period in the prior year. Capital expenditures also increased during the current year by $7.1 million when compared to the prior year. Offset to the increase, was proceeds from sale of assets as a result of completion of the required divestiture of selected assets related to the MedServe acquisition for $8.0 million in 2010.

 

23


Table of Contents

Net cash used in financing activities was $49.7 million during the six months ended June 30, 2010 compared to $54.4 million for the comparable period in 2009. We had a decrease of $20.0 million due to debt repayments and financing fees, and a $5.7 million decrease in repurchase and cancellation of common stock in 2010 compare to 2009. We had new term loan in 2009 of $50.0 million.

Guarantees: We have guaranteed a loan to JPMorganChase Bank N.A. on behalf of Shiraishi-Sogyo Co. Ltd (“Shiraishi”). Shiraishi is a customer in Japan that is expanding their medical waste management business and has a one year loan with a current balance of $5.6 million with JPMorganChase Bank N.A. that expires in May 2011. We also have extended notes receivable to Shiraishi for approximately $14.9 million in support of their medical waste business. These amounts are collateralized with the assets of Shiraishi and related companies.

Annual Impairment Test: We completed our annual goodwill impairment test during the second quarter of 2010. We used both a market approach and an income approach to determine the fair value of our reporting units. The market approach compares the market capitalization of the company as a whole, which is the fair value, and allocates a portion of that fair value to each reporting unit based on that reporting unit’s historic cash flows, as measured by a modified Earnings Before Interest, Taxes, Depreciation, and Amortization. The income approach uses estimates of future cash flows discounted to a present value to arrive at a fair value. Both the market and income approaches indicated no impairment to any of our three reporting units.

ITEM 3. QUALITATIVE AND QUANTITATIVE DISCLOSURES ABOUT MARKET RISK

We are subject to market risks arising from changes in interest rates. As of June 30, 2010, we have one interest rate swap contract covering $25 million of our borrowings outstanding under our senior credit facility, and two Treasury rate locks covering $150 million of our expected private debt placement. The objective of the hedges is to reduce the risk of volatile interest expense by fixing the rate. The details of the contracts are as follows:

 

In thousands

Notional
Amount

   Fixed
Interest Rate
   

Variable Interest Rate

  

Expiration Date

$25,000    2.94   1 Month Libor    October 2010
$75,000    2.799   7-Year Treasury    July 2010
$75,000    3.29   10-Year Treasury    July 2010

 

24


Table of Contents

We entered into the interest rate hedges in order to manage the risk of interest rate changes to our interest expense. The interest rate hedges are designated as cash flow hedges; the notional amounts and all other significant terms of the hedge agreement are matched to the provisions and terms of the variable rate debt hedged. The fair market of the three hedges is recorded as a current liability of $3.8 million at June 30, 2010. At June 30, 2010, the hedges were determined to be 100% effective. Gains or losses on hedges are reclassified into interest expense when the effect of the hedged item is recognized in earnings. The fair market value was determined using market data inputs to calculate expected future interest rates. The cash streams attributable to the difference between expected future rates and the fixed rate payable is discounted to arrive at the fair value of the two hedges.

Our potential additional interest expense over one year that would result from a hypothetical, instantaneous and unfavorable change of 100 basis points in the interest rate on all of our variable rate obligations would be approximately $6.0 million on a pre-tax basis.

We have exposure to foreign currency fluctuations. We have subsidiaries in nine foreign countries whose functional currency is the local currency. Changes in foreign currency exchange rates could unfavorably impact our consolidated results of operations. We have exposure to commodity pricing for gas and diesel fuel for our trucks and for the purchase of containers and boxes. We do not hedge these items to manage the exposure.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Our management, with the participation of our President and Chief Executive Officer and our Chief Financial Officer, conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter covered by this Report. On the basis of this evaluation, our President and Chief Executive Officer and our Chief Financial Officer each concluded that our disclosure controls and procedures were effective.

The term “disclosure controls and procedures” is defined in Rule 13a-14(e) of the Securities Exchange Act of 1934 as “controls and other procedures designed to ensure that information required to be disclosed by the issuer in the reports, files or submits under the Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms.” Our disclosure controls and procedures are designed to ensure that material information relating to us and our consolidated subsidiaries is accumulated and communicated to our management, including our President and Chief Executive Officer and our Chief Financial Officer, as appropriate to allow timely decisions regarding our required disclosures.

Internal Control Over Financial Reporting

During the quarter ended June 30, 2010, there were no changes in our internal controls over financial reporting that have materially affected, or are reasonably likely materially to affect, our internal controls over financial reporting.

 

25


Table of Contents

FROM TIME TO TIME WE ISSUE FORWARD-LOOKING STATEMENTS RELATING TO SUCH THINGS AS ANTICIPATED FINANCIAL PERFORMANCE, BUSINESS PROSPECTS, ACQUISITION ACTIVITIES AND SIMILAR MATTERS.

THESE FORWARD-LOOKING STATEMENTS MAY INVOLVE RISKS AND UNCERTAINTIES, SOME OF WHICH ARE BEYOND OUR CONTROL (FOR EXAMPLE, GENERAL ECONOMIC CONDITIONS). OUR ACTUAL RESULTS COULD DIFFER SIGNIFICANTLY FROM THE RESULTS DESCRIBED IN THE FORWARD-LOOKING STATEMENTS. FACTORS THAT COULD CAUSE SUCH DIFFERENCES INCLUDE DIFFICULTIES IN COMPLETING THE INTEGRATION OF ACQUIRED BUSINESSES, CHANGES IN GOVERNMENTAL REGULATION OF MEDICAL WASTE COLLECTION AND TREATMENT, AND INCREASES IN TRANSPORTATION AND OTHER OPERATING COSTS, AS WELL AS VARIOUS OTHER FACTORS.

 

26


Table of Contents

PART II. – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

See Note 13 - Legal Proceedings, in the Notes to the Condensed Consolidated Financial Statements (Item 1 of Part I).

ITEM 2. CHANGES IN SECURITIES, USES OF PROCEEDS AND ISSUER

PURCHASES OF EQUITY SECURITIES

Under resolutions that our Board of Directors adopted in May 2002, February 2005, February 2007, May 2007 and May 2008, we have been authorized to purchase a cumulative total of 16,224,578 shares of our common stock on the open market. As of June 30, 2010, we had purchased a cumulative total of 13,628,667 shares.

The following table provides information about our purchases during the six months ended June 30, 2010 of shares of our common stock:

Issuer Purchase of Equity Securities

 

Period

   Total
Number of
Share (or
Units)
Purchased
   Average
Price Paid
per Share
(or Unit)
   Number of
Shares (or
Units)
Purchased
as Part of
Publicly
Announced
Plans  or
Programs
   Maximum Number
(or Approximate
Dollar Value) of
Shares (or Units)
that  May Yet Be
Purchased Under
the Plans or
Programs

January 1- January 31, 2010

   —      $ —      —      3,038,461

February 1- February 28, 2010

   8,609      50.91    8,609    3,029,852

March 1- March 31, 2010

   198,505      54.51    198,505    2,831,347

April 1- April 30, 2010

   100,656      54.37    100,656    2,730,691

May 1- May 31, 2010

   134,780      55.85    134,780    2,595,911

June 1- June 30, 2010

   —        —      —      2,595,911

 

27


Table of Contents

ITEM 6. EXHIBITS

 

31.1    Rules 13a-14(a)/15d-14(a) Certification of Mark C. Miller, Chairman, President and Chief Executive Officer
31.2    Rule 13a-14(a)/15d-14(a) Certification of Frank J.M. ten Brink, Executive Vice President and Chief Financial Officer
32    Section 1350 Certification of Mark C. Miller, Chairman, President and Chief Executive Officer, and Frank J.M. ten Brink, Executive Vice President and Chief Financial Officer
101.INS XBRL    Instance Document
101.SCH XBRL    Taxonomy Extension Schema Document
101.CAL XBRL    Taxonomy Extension Calculation Linkbase Document
101.DEF XBRL    Taxonomy Definition Linkbase Document
101.LAB XBRL    Taxonomy Extension Label Linkbase Document
101.PRE XBRL    Taxonomy Extension Presentation Linkbase Document

 

28


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: August 9, 2010

 

STERICYCLE, INC.
(Registrant)
By:  

/s/    Frank J.M. ten Brink        

  Frank J.M. ten Brink
  Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)

 

29